Form 10-Q CHEMBIO DIAGNOSTICS, For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Chembio Diagnostics (CEMI) Reports Q2 GAAP Loss of $0.86/Share
August 11, 2016 8:34 AM EDTChembio Diagnostics (NASDAQ: CEMI) reported Q2 EPS of ($0.86), versus ($0.07) reported last year. Revenue for the quarter came in at $3.27 million, versus $6.72 million reported last year.
The net loss in the 2016 period includes a tax provision for the recording of a valuation allowance on... More
